Cipla News

Cipla Limited (India) News

Cipla sales growth slows, but net profit close to expectations

Cipla sales growth slows, but net profit close to expectations

Livemint - 34 minutes ago
It was an unusual September quarter for pharmaceutical firm Cipla Ltd. Revenues grew by only 6.7% over the year-ago period, versus a 14% growth in the previous quarter. But net profit at Rs276 ...

TABLE-India's Cipla Q2 net profit jumps 83 pct

TABLE-India's Cipla Q2 net profit jumps 83 pct

Interactive Investor - 11 minutes ago
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. Registered Office: Standon House, 21 Mansell Street ...

Market Live

Market Live

Economic Times - 22 minutes ago
10:17 am: The top 10 gainers among the 50 Nifty stocks were Ranbaxy Laboratories (1.95%), ITC (1.56%), Maruti Suzuki (1.27%), HDFC, Punjab National Bank, Tata Power, Cipla, Sun Pharmaceutical ...

Cipla to declare Q2 results on Oct 28, 2009

Cipla to declare Q2 results on Oct 28, 2009

Equity Bulls - 52 minutes ago
Cipla Ltd has announced that a meeting of the Board of Directors of the Company will be held on October 28, 2009, inter alia, to consider Unaudited Financial Results for second quarter ended ...

'Made in India' dominates US AIDS scheme

'Made in India' dominates US AIDS scheme

Sify - 1 hour ago
Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency Plan for AIDS Relief (Pepfar). Out of the 100 approvals by the US drug regulator ...

Storm over drug-patent linkage after court rejects Bayer petition

Storm over drug-patent linkage after court rejects Bayer petition

Livemint - 56 minutes ago
The global debate on patented medicines versus generics has for decades elicited strong reactions—pharmaceutical multinationals oppose generic formulations on the ground that they unfairly cut ...

War of contraceptive pills raises issues of control

War of contraceptive pills raises issues of control

DNA India - 53 minutes ago
Cipla and Mankind Pharma are engaged in a big battle for supremacy in the Indian oral contraceptives market. Over the past few months, I-pill and Unwanted-72, the two companies' brands ...

Syndicate content